Skip to main content
Educational comparison - not medical advice. This page compares two compounds for informational purposes. Neither is recommended as treatment. Any protocol decision is a conversation with your licensed healthcare provider.
Home/Peptides/GHK-Cu vs BPC-157
HEAD-TO-HEAD COMPARISON

GHK-Cu vs BPC-157

Users building healing + aesthetic protocols.

QUICK ANSWER

GHK-Cu is a copper-binding peptide driving collagen synthesis + skin remodeling - primarily topical and systemic aesthetic/anti-aging use. BPC-157 is a gastric-derived peptide driving tissue repair + gut healing - primarily local/systemic injectable injury use. Key specs: GHK-Cu (Cosmetic, ~minutes in plasma; tissue effects persist much longer, Subcutaneous or topical) vs BPC-157 (Healing, 30–60 minutes (systemic), with extended local tissue half-life, Subcutaneous or intramuscular).

OPTION A
GHK-Cu
GHK-Cu (Copper Peptide)
Copper-binding tripeptide with systemic anti-inflammatory effects and the flagship peptide for skin, collagen, and wound healing.
Full profile →
OPTION B
BPC-157
Body Protection Compound-157
Synthetic 15-amino-acid peptide derived from human gastric juice, studied for tissue repair and gut healing.
Full profile →
THE CORE DIFFERENCE

GHK-Cu is a copper-binding peptide driving collagen synthesis + skin remodeling - primarily topical and systemic aesthetic/anti-aging use. BPC-157 is a gastric-derived peptide driving tissue repair + gut healing - primarily local/systemic injectable injury use. They're commonly stacked ("Glow Stack" when combined with Epithalon) because their mechanisms are completely non-overlapping.

BEST FOR
Recover Faster →Longevity →Skin & Aesthetics →Women's Longevity →Gut Health →Immunity →
Each protocol guide pairs the relevant compounds with the supplement stack that supports them and the biomarkers that show whether it’s working.
FEATURE COMPARISON
GHK-Cu
BPC-157
Full name
GHK-Cu (Copper Peptide)
Body Protection Compound-157
Category
Cosmetic
Healing
FDA status
Not FDA-approved systemically. Topical formulations widely available OTC.
Not FDA-approved. Available via 503A compounding pharmacies (Category 1, post-2026 reclassification).
Half-life
~minutes in plasma; tissue effects persist much longer
30–60 minutes (systemic), with extended local tissue half-life
Typical dosing
1–2 mg SC 2–3× weekly (systemic) or 0.05–0.2% topical (skin)
200–500 mcg/day, subcutaneous injection near injury site or systemic
Route
Subcutaneous or topical
Subcutaneous or intramuscular
Classification
Naturally-occurring copper-bound tripeptide (Gly-His-Lys)
Synthetic pentadecapeptide
BIOMARKERS COMMONLY TRACKED
On GHK-Cu
  • • Serum copper
  • • Ceruloplasmin
  • • hs-CRP
  • • Ferritin
On BPC-157
  • • hs-CRP (inflammation)
  • • CBC with differential
  • • Ferritin
  • • IGF-1 (when stacked)
CALCULATOR
GHK-Cu reconstitution →
CALCULATOR
BPC-157 reconstitution →
CONDITIONS USERS RESEARCH THESE FOR
Informational only - neither compound is presented as a treatment for any condition. These are contexts in which users research these compounds and discuss them with their licensed provider.
INFLAMMATION
Chronic Low-Grade Inflammation
The persistent low-level inflammatory pattern linked to cardiovascular, metabolic, and cognitive disease - trackable via specific markers.
RECOVERY
Poor Recovery / Overtraining
The pattern users see when training load exceeds recovery capacity - trackable via HRV, RHR, and specific biomarkers.
RELATED COMPARISONS
BPC-157 vs TB-500
FREQUENTLY ASKED QUESTIONS

What is the difference between GHK-Cu and BPC-157?

GHK-Cu is a copper-binding peptide driving collagen synthesis + skin remodeling - primarily topical and systemic aesthetic/anti-aging use. BPC-157 is a gastric-derived peptide driving tissue repair + gut healing - primarily local/systemic injectable injury use. They're commonly stacked ("Glow Stack" when combined with Epithalon) because their mechanisms are completely non-overlapping.

Who typically researches GHK-Cu vs BPC-157?

Users building healing + aesthetic protocols. GHK-Cu (Cosmetic, ~minutes in plasma; tissue effects persist much longer, Subcutaneous or topical) and BPC-157 (Healing, 30–60 minutes (systemic), with extended local tissue half-life, Subcutaneous or intramuscular) differ in mechanism and dosing cadence - the right choice depends on protocol goals, biomarker baseline, and provider guidance. MyProtocolStack lets you log doses and lab values for both side-by-side if you're cycling between them.

What blood markers do users track on GHK-Cu or BPC-157?

Biomarkers commonly tracked across GHK-Cu and BPC-157 protocols include Serum copper, Ceruloplasmin, hs-CRP, Ferritin, hs-CRP (inflammation), CBC with differential, IGF-1 (when stacked). Establishing a baseline before starting and re-drawing at consistent intervals lets you measure each compound's effect against your own reference point - generic lab ranges are less informative than your personal trend over time. MyProtocolStack tracks these biomarkers in the context of whichever compound you're currently running.

Whichever you're tracking, we built the dashboard for it.

Log doses, upload labs, watch the biomarkers trend. StackAI reads your panel in context of what you're actually running.

Start tracking free →

Informational comparison only - not medical advice. Research-stage compounds discussed are not FDA-approved unless specifically noted. Any protocol decision should be made with a licensed healthcare provider.